According to Soligenix's latest financial reports the company has $8.44 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $13.35 M | -48.7% |
2021-12-31 | $26.04 M | 39.45% |
2020-12-31 | $18.67 M | 244.54% |
2019-12-31 | $5.42 M | -39.66% |
2018-12-31 | $8.98 M | 15.04% |
2017-12-31 | $7.8 M | -10.98% |
2016-12-31 | $8.77 M | 78.25% |
2015-12-31 | $4.92 M | -10.92% |
2014-12-31 | $5.52 M | -5.65% |
2013-12-31 | $5.85 M | 74.48% |
2012-12-31 | $3.35 M | -44.03% |
2011-12-31 | $5.99 M | -19.53% |
2010-12-31 | $7.45 M | -3.12% |
2009-12-31 | $7.69 M | 421.33% |
2008-12-31 | $1.47 M | -33.54% |
2007-12-31 | $2.22 M | 1755.74% |
2006-12-31 | $0.11 M | -85.44% |
2005-12-31 | $0.82 M | -64.77% |
2004-12-31 | $2.33 M | -43.36% |
2003-12-31 | $4.11 M | -0.71% |
2002-12-31 | $4.14 M | -58.29% |
2001-12-31 | $9.94 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $22.92 B | 271,348.80% | ๐บ๐ธ USA |
Pfizer PFE | $12.69 B | 150,145.79% | ๐บ๐ธ USA |
Sanofi SNY | $9.92 B | 117,446.20% | ๐ซ๐ท France |
Onconova Therapeutics ONTX | $25.24 M | 198.88% | ๐บ๐ธ USA |
Athersys ATHX | $1.02 M | -87.92% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $3.22 B | 38,094.87% | ๐ฎ๐ฑ Israel |
Cleveland BioLabs
CBLI | N/A | N/A | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | $0.11 B | 1,222.49% | ๐บ๐ธ USA |